Ligand-Based Drug Design

In situations where protein structural data is lacking, Sygnature Discovery boasts an array of Ligand-Based Drug Design tools tailored to enhance the drug discovery process across various phases.

Key Drug Design Techniques:

  • Scaffold hopping and fragment replacement tools have proven very effective as a strategy to generate novel IP and ideas for back-up series or to replace a structural element associated with metabolic instability or unwanted properties.
  • Several pharmacophoric techniques and alignment methods based on ligand shape and electrostatic similarity can be used to compare different series of compounds and their structure-activity relationship (SAR) data or for virtual screening to rapidly identify novel potentially active compounds.
  • Local QSAR models (2D and 3D), Free-Wilson models, matched molecular pair analysis and machine learning using project data can all be used to predict potency against the target of interest and/or ADMET properties for new compounds. These may be used in concert to create protocols for multi-objective optimisation.
  • Conformational analysis and QM geometry optimisation provides an understanding compound flexibility and its predisposition for the optimal bioactive conformation.

A knowledge-based approach for Lead Identification is a very efficient way of developing novel chemical matter using Ligand-based computational tools to design new scaffolds or molecular fragments. Our experienced teams have generated several novel lead series in this way.

Latest News

View All

Sygnature Discovery Receives EcoVadis Award For Sustainable…

Sygnature Discovery goes for global industry recognition…

First patients dosed in Phase 1a clinical…

Sygnature Discovery Appoints Industry Leaders To Board…